{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:18:01Z","timestamp":1783423081900,"version":"3.54.6"},"reference-count":302,"publisher":"IMR Press","issue":"6","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Dehydrogenases function as metabolic gatekeepers, regulating carbon flux, redox balance, and biosynthetic capacity at critical branch points in cellular metabolism. This narrative review examines six key dehydrogenases, namely glyceraldehyde-3-phosphate dehydrogenase (GAPDH), lactate dehydrogenase (LDH), pyruvate dehydrogenase complex (PDHC), malate dehydrogenase (MDH1\/2), isocitrate dehydrogenase (IDH1\/2\/3), and glucose-6-phosphate dehydrogenase (G6PDH), that collectively orchestrate the partitioning of nutrients among energy production, biosynthesis, and redox homeostasis. These enzymes share common features, including cofactor-dependent catalysis (NAD+\/NADH or NADP+\/NADPH), strategic positioning at metabolic nodes, and integration of compartmentalized metabolism between the cytosol and mitochondria. Under physiologic conditions, these dehydrogenases enable metabolic flexibility, allowing cells to adapt nutrient utilization to changing energetic demands and biosynthetic requirements. However, their dysregulation drives pathogenesis across diverse human diseases. In cancer, altered dehydrogenase activity supports metabolic reprogramming, exemplified by the Warburg effect mediated by LDHA, oncometabolite production (mutant IDH1\/2), and enhanced biosynthetic capacity associated with G6PDH activity. Metabolic syndrome and diabetes feature PDHC suppression via pyruvate dehydrogenase kinase (PDK) upregulation, contributing to metabolic inflexibility and impaired glucose oxidation. Inherited enzymopathies, including G6PDH and PDHC deficiencies, underscore the essential roles of these enzymes and their tissue-specific requirements. In neurodegenerative disorders, oxidative modification of GAPDH promotes protein aggregation, whereas age-related decline in NAD+ compromises the activity of multiple NAD+-dependent dehydrogenases in a tissue- and context-dependent manner. The central importance of these enzymes has generated substantial therapeutic interest. Successful clinical translation includes mutant IDH inhibitors that reverse oncometabolite-driven epigenetic reprogramming in cancer. However, targeting essential metabolic enzymes presents challenges, including narrow therapeutic windows, metabolic compensation, and tissue-specific toxicities. Future therapeutic strategies will likely focus on exploiting disease-specific vulnerabilities, developing isoform-selective inhibitors, and combining metabolic interventions with conventional therapies. Understanding these six dehydrogenase gatekeepers provides crucial insights into metabolic regulation and highlights opportunities for precision-medicine approaches targeting the metabolic dependencies of human disease.<\/jats:p>","DOI":"10.31083\/fbl49369","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:50:51Z","timestamp":1783421451000},"source":"Crossref","is-referenced-by-count":0,"title":["Six Dehydrogenase Gatekeepers of Carbohydrate Metabolism: Metabolic Integration in Health and Disease"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-8839","authenticated-orcid":true,"given":"Christos","family":"Papaneophytou","sequence":"first","affiliation":[{"name":"Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Petrou","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"May SW. Applications of oxidoreductases. Current Opinion in Biotechnology. 1999; 10: 370\u2013375.","DOI":"10.1016\/S0958-1669(99)80067-6"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Bollella P, Gorton L, Antiochia R. Direct Electron Transfer of Dehydrogenases for Development of 3rd Generation Biosensors and Enzymatic Fuel Cells. Sensors (Basel, Switzerland). 2018; 18: 1319.","DOI":"10.3390\/s18051319"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Sell\u00e9s Vidal L, Kelly CL, Mordaka PM, Heap JT. Review of NAD(P)H-dependent oxidoreductases: Properties, engineering and application. Biochimica et Biophysica Acta. Proteins and Proteomics. 2018; 1866: 327\u2013347.","DOI":"10.1016\/j.bbapap.2017.11.005"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Xiao W, Wang RS, Handy DE, Loscalzo J. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. Antioxidants & Redox Signaling. 2018; 28: 251\u2013272.","DOI":"10.1089\/ars.2017.7216"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Meijers R, Morris RJ, Adolph HW, Merli A, Lamzin VS, Cedergren-Zeppezauer ES. On the enzymatic activation of NADH. The Journal of Biological Chemistry. 2001; 276: 9316\u20139321.","DOI":"10.1074\/jbc.M010870200"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Iyanagi T. Molecular mechanism of metabolic NAD(P)H-dependent electron-transfer systems: The role of redox cofactors. Biochimica et Biophysica Acta. Bioenergetics. 2019; 1860: 233\u2013258.","DOI":"10.1016\/j.bbabio.2018.11.014"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Ferraris DM, Gelardi ELM, Garavaglia S, Miggiano R, Rizzi M. Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancer. Biochemical Society Transactions. 2020; 48: 693\u2013707.","DOI":"10.1042\/BST20191261"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Chen X, Ding J. Molecular insights into the catalysis and regulation of mammalian NAD-dependent isocitrate dehydrogenases. Current Opinion in Structural Biology. 2023; 82: 102672.","DOI":"10.1016\/j.sbi.2023.102672"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Migaud ME, Ziegler M, Baur JA. Regulation of and challenges in targeting NAD+ metabolism. Nature Reviews. Molecular Cell Biology. 2024; 25: 822\u2013840.","DOI":"10.1038\/s41580-024-00752-w"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Ding N, Yuan Z, Sun L, Yin L. Dynamic and Static Regulation of Nicotinamide Adenine Dinucleotide Phosphate: Strategies, Challenges, and Future Directions in Metabolic Engineering. Molecules (Basel, Switzerland). 2024; 29: 3687.","DOI":"10.3390\/molecules29153687"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduction and Targeted Therapy. 2020; 5: 227.","DOI":"10.1038\/s41392-020-00311-7"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Liu H, Wang S, Wang J, Guo X, Song Y, Fu K, et al. Energy metabolism in health and diseases. Signal Transduction and Targeted Therapy. 2025; 10: 69.","DOI":"10.1038\/s41392-025-02141-x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"J\u00f6rnvall H, Persson B, Krook M, Atrian S, Gonz\u00e0lez-Duarte R, Jeffery J, et al. Short-chain dehydrogenases\/reductases (SDR). Biochemistry. 1995; 34: 6003\u20136013.","DOI":"10.1021\/bi00018a001"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Persson B, Jeffery J, J\u00f6rnvall H. Different segment similarities in long-chain dehydrogenases. Biochemical and Biophysical Research Communications. 1991; 177: 218\u2013223.","DOI":"10.1016\/0006-291x(91)91970-n"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Persson B, Kallberg Y, Bray JE, Bruford E, Dellaporta SL, Favia AD, et al. The SDR (short-chain dehydrogenase\/reductase and related enzymes) nomenclature initiative. Chemico-biological Interactions. 2009; 178: 94\u201398.","DOI":"10.1016\/j.cbi.2008.10.040"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Kavanagh KL, J\u00f6rnvall H, Persson B, Oppermann U. Medium- and short-chain dehydrogenase\/reductase gene and protein families : the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cellular and Molecular Life Sciences : CMLS. 2008; 65: 3895\u20133906.","DOI":"10.1007\/s00018-008-8588-y"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Shin WH, Kihara D. 55 Years of the Rossmann Fold. Methods in Molecular Biology (Clifton, N.J.). 2019; 1958: 1\u201313.","DOI":"10.1007\/978-1-4939-9161-7_1"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kallberg Y, Persson B. Prediction of coenzyme specificity in dehydrogenases\/reductases. A hidden Markov model-based method and its application on complete genomes. The FEBS Journal. 2006; 273: 1177\u20131184.","DOI":"10.1111\/j.1742-4658.2006.05153.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Sun P, Liu Y, Ma T, Ding J. Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase. Cell Discovery. 2020; 6: 94.","DOI":"10.1038\/s41421-020-00220-7"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Solanki K, Abdallah W, Banta S. Engineering the cofactor specificity of an alcohol dehydrogenase via single mutations or insertions distal to the 2'-phosphate group of NADP(H). Protein Engineering, Design & Selection : PEDS. 2017; 30: 373\u2013380.","DOI":"10.1093\/protein\/gzx009"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Zhou F, Xu Y, Nie Y, Mu X. Substrate-Specific Engineering of Amino Acid Dehydrogenase Superfamily for Synthesis of a Variety of Chiral Amines and Amino Acids. Catalysts. 2022; 12: 380.","DOI":"10.3390\/catal12040380"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Qian L, Mohanty P, Jayaraman A, Mittal J, Zhu X. Specific residues and conformational plasticity define the substrate specificity of short-chain dehydrogenases\/reductases. The Journal of Biological Chemistry. 2024; 300: 105596.","DOI":"10.1016\/j.jbc.2023.105596"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Liu S, Liu J, Wang Y, Deng F, Deng Z. Oxidative Stress: Signaling Pathways, Biological Functions, and Disease. MedComm. 2025; 6: e70268.","DOI":"10.1002\/mco2.70268"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Schiliro C, Firestein BL. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation [Erratum in: Cells. 2022; 11: 3593.  Cells. 2021; 10: 1056. https:\/\/doi.org\/10.3390\/cells10051056","DOI":"10.3390\/cells11223593.]"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Acierno C, Barletta F, Nevola R, Rinaldi L, Sasso FC, Adinolfi LE, et al. Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure-A Molecular Perspective. International Journal of Molecular Sciences. 2025; 26: 5574.","DOI":"10.3390\/ijms26125574"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Research Integrity and Peer Review. 2019; 4: 5.","DOI":"10.1186\/s41073-019-0064-8"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Chandel NS. Carbohydrate Metabolism. Cold Spring Harbor Perspectives in Biology. 2021; 13: a040568.","DOI":"10.1101\/cshperspect.a040568"},{"key":"ref28","unstructured":"Nakrani MN, Wineland RH, Anjum F. Physiology, Glucose Metabolism. StatPearls: Treasure Island (FL). 2023."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Kierans SJ, Taylor CT. Glycolysis: A multifaceted metabolic pathway and signaling hub. The Journal of Biological Chemistry. 2024; 300: 107906.","DOI":"10.1016\/j.jbc.2024.107906"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Chandel NS. Glycolysis. Cold Spring Harbor Perspectives in Biology. 2021; 13: a040535.","DOI":"10.1101\/cshperspect.a040535"},{"key":"ref31","unstructured":"Melkonian EA, Schury MP. Biochemistry, Anaerobic Glycolysis. StatPearls: Treasure Island, FL, USA. 2024."},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Gr\u00fcning N-M, Ralser M. Glycolysis: How a 300yr long research journey that started with the desire to improve alcoholic beverages kept revolutionizing biochemistry. Current Opinion in Systems Biology. 2021; 28: 100380.","DOI":"10.1016\/j.coisb.2021.100380"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends in Biochemical Sciences. 2016; 41: 211\u2013218.","DOI":"10.1016\/j.tibs.2015.12.001"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Rabinowitz JD, Enerb\u00e4ck S. Lactate: the ugly duckling of energy metabolism. Nature Metabolism. 2020; 2: 566\u2013571.","DOI":"10.1038\/s42255-020-0243-4"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Papaneophytou C. The Warburg Effect: Is it Always an Enemy? Frontiers in Bioscience (Landmark Edition). 2024; 29: 402.","DOI":"10.31083\/j.fbl2912402"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Schurr A. How the 'Aerobic\/Anaerobic Glycolysis' Meme Formed a 'Habit of Mind' Which Impedes Progress in the Field of Brain Energy Metabolism. International Journal of Molecular Sciences. 2024; 25: 1433.","DOI":"10.3390\/ijms25031433"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Rogatzki MJ, Ferguson BS, Goodwin ML, Gladden LB. Lactate is always the end product of glycolysis. Frontiers in Neuroscience. 2015; 9: 22.","DOI":"10.3389\/fnins.2015.00022"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Ghani MU, Yang Z, Feng T, Chen J, Khosravi Z, Wu Q, et al. Comprehensive review on glucose 6 phosphate dehydrogenase: A critical immunometabolic and redox switch in insects. International Journal of Biological Macromolecules. 2024; 273: 132867.","DOI":"10.1016\/j.ijbiomac.2024.132867"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annual Review of Nutrition. 1999; 19: 379\u2013406.","DOI":"10.1146\/annurev.nutr.19.1.379"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Han HS, Kang G, Kim JS, Choi BH, Koo SH. Regulation of glucose metabolism from a liver-centric perspective. Experimental & Molecular Medicine. 2016; 48: e218.","DOI":"10.1038\/emm.2015.122"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Lazarev VF, Guzhova IV, Margulis BA. Glyceraldehyde-3-phosphate Dehydrogenase is a Multifaceted Therapeutic Target. Pharmaceutics. 2020; 12: 416.","DOI":"10.3390\/pharmaceutics12050416"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annual Review of Cell and Developmental Biology. 2011; 27: 441\u2013464.","DOI":"10.1146\/annurev-cellbio-092910-154237"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Hanse EA, Ruan C, Kachman M, Wang D, Lowman XH, Kelekar A. Cytosolic malate dehydrogenase activity helps support glycolysis in actively proliferating cells and cancer. Oncogene. 2017; 36: 3915\u20133924.","DOI":"10.1038\/onc.2017.36"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Yamasaki M, Yamada K, Furuya S, Mitoma J, Hirabayashi Y, Watanabe M. 3-Phosphoglycerate dehydrogenase, a key enzyme for l-serine biosynthesis, is preferentially expressed in the radial glia\/astrocyte lineage and olfactory ensheathing glia in the mouse brain. The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. 2001; 21: 7691\u20137704.","DOI":"10.1523\/JNEUROSCI.21-19-07691.2001"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Tristan C, Shahani N, Sedlak TW, Sawa A. The diverse functions of GAPDH: views from different subcellular compartments. Cellular Signalling. 2011; 23: 317\u2013323.","DOI":"10.1016\/j.cellsig.2010.08.003"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Claps G, Faouzi S, Quidville V, Chehade F, Shen S, Vagner S, et al. The multiple roles of LDH in cancer. Nature Reviews. Clinical Oncology. 2022; 19: 749\u2013762.","DOI":"10.1038\/s41571-022-00686-2"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Patel MS, Nemeria NS, Furey W, Jordan F. The pyruvate dehydrogenase complexes: structure-based function and regulation. The Journal of Biological Chemistry. 2014; 289: 16615\u201316623.","DOI":"10.1074\/jbc.R114.563148"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. American Journal of Physiology. Endocrinology and Metabolism. 2009; 297: E578\u2013E591.","DOI":"10.1152\/ajpendo.00093.2009"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"de Lorenzo L, Stack TMM, Fox KM, Walstrom KM. Catalytic mechanism and kinetics of malate dehydrogenase. Essays in Biochemistry. 2024; 68: 73\u201382.","DOI":"10.1042\/EBC20230086"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Al-Khallaf H. Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight. Cell & Bioscience. 2017; 7: 37.","DOI":"10.1186\/s13578-017-0165-3"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Shah SS, Stone EF, Francis RO, Karafin MS. The global role of G6PD in infection and immunity. Frontiers in Immunology. 2024; 15: 1393213.","DOI":"10.3389\/fimmu.2024.1393213"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Stincone A, Prigione A, Cramer T, Wamelink MMC, Campbell K, Cheung E, et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biological Reviews of the Cambridge Philosophical Society. 2015; 90: 927\u2013963.","DOI":"10.1111\/brv.12140"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Blood. 2020; 136: 1225\u20131240.","DOI":"10.1182\/blood.2019000944"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Hecker PA, Leopold JA, Gupte SA, Recchia FA, Stanley WC. Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. American Journal of Physiology. Heart and Circulatory Physiology. 2013; 304: H491\u2013500.","DOI":"10.1152\/ajpheart.00721.2012"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Stanton RC. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life. 2012; 64: 362\u2013369.","DOI":"10.1002\/iub.1017"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Kim YK, Kim H. Emerging Roles of Post-Translational Modifications in Metabolic Homeostasis and Type 2 Diabetes. International Journal of Molecular Sciences. 2025; 26: 11552.","DOI":"10.3390\/ijms262311552"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Zhong Q, Xiao X, Qiu Y, Xu Z, Chen C, Chong B, et al. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm. 2023; 4: e261.","DOI":"10.1002\/mco2.261"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Zhou M, Qin Z, Zhu X, Ruan Y, Ling H, Li C, et al. Pyruvate dehydrogenase kinases: key regulators of cellular metabolism and therapeutic targets for metabolic diseases. Journal of Physiology and Biochemistry. 2025; 81: 21\u201334.","DOI":"10.1007\/s13105-025-01068-9"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Tossounian MA, Zhang B, Gout I. The Writers, Readers, and Erasers in Redox Regulation of GAPDH. Antioxidants (Basel, Switzerland). 2020; 9: 1288.","DOI":"10.3390\/antiox9121288"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Yu W, Dittenhafer-Reed KE, Denu JM. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. The Journal of Biological Chemistry. 2012; 287: 14078\u201314086.","DOI":"10.1074\/jbc.M112.355206"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature. 2012; 481: 385\u2013388.","DOI":"10.1038\/nature10642"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 2011; 481: 380\u2013384.","DOI":"10.1038\/nature10602"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Jiang L, Shestov AA, Swain P, Yang C, Parker SJ, Wang QA, et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature. 2016; 532: 255\u2013258.","DOI":"10.1038\/nature17393"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Yang H, Zhou L, Shi Q, Zhao Y, Lin H, Zhang M, et al. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth. The EMBO Journal. 2015; 34: 1110\u20131125.","DOI":"10.15252\/embj.201591041"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Lin Y, Wang Y, Li PF. Mutual regulation of lactate dehydrogenase and redox robustness. Frontiers in Physiology. 2022; 13: 1038421.","DOI":"10.3389\/fphys.2022.1038421"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Wu F, Muskat NH, Dvilansky I, Koren O, Shahar A, Gazit R, et al. Acetylation-dependent coupling between G6PD activity and apoptotic signaling. Nature Communications. 2023; 14: 6208.","DOI":"10.1038\/s41467-023-41895-2"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Meng Q, Zhang Y, Hao S, Sun H, Liu B, Zhou H, et al. Recent findings in the regulation of G6PD and its role in diseases. Frontiers in Pharmacology. 2022; 13: 932154.","DOI":"10.3389\/fphar.2022.932154"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Seidler NW. Basic Biology of GAPDH. In GAPDH: Biological Properties and Diversity (pp. 1\u201336). Springer Netherlands: Dordrecht. 2013.","DOI":"10.1007\/978-94-007-4716-6_1"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Mitsuzawa H, Kimura M, Kanda E, Ishihama A. Glyceraldehyde-3-phosphate dehydrogenase and actin associate with RNA polymerase II and interact with its Rpb7 subunit. FEBS Letters. 2005; 579: 48\u201352.","DOI":"10.1016\/j.febslet.2004.11.045"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Jarosz AP, Wei W, Gauld JW, Auld J, \u00d6zcan F, Aslan M, et al. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is inactivated by S-sulfuration in vitro. Free Radical Biology & Medicine. 2015; 89: 512\u2013521.","DOI":"10.1016\/j.freeradbiomed.2015.09.007"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Urrutia AA, Mesa-Ciller C, Guajardo-Grence A, Alkan HF, Soro-Arn\u00e1iz I, Vandekeere A, et al. HIF1\u03b1-dependent uncoupling of glycolysis suppresses tumor cell proliferation. Cell Reports. 2024; 43: 114103.","DOI":"10.1016\/j.celrep.2024.114103"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Wang J, Yu X, Cao X, Tan L, Jia B, Chen R, et al. GAPDH: A common housekeeping gene with an oncogenic role in pan-cancer. Computational and Structural Biotechnology Journal. 2023; 21: 4056\u20134069.","DOI":"10.1016\/j.csbj.2023.07.034"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Nicholls C, Li H, Liu JP. GAPDH: a common enzyme with uncommon functions. Clinical and Experimental Pharmacology & Physiology. 2012; 39: 674\u2013679.","DOI":"10.1111\/j.1440-1681.2011.05599.x"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Talwar D, Miller CG, Grossmann J, Szyrwiel L, Schwecke T, Demichev V, et al. The GAPDH redox switch safeguards reductive capacity and enables survival of stressed tumour cells. Nature Metabolism. 2023; 5: 660\u2013676.","DOI":"10.1038\/s42255-023-00781-3"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"El Khoury A, Papaneophytou C. Flipping the Target: Evaluating Natural LDHA Inhibitors for Selective LDHB Modulation. Molecules (Basel, Switzerland). 2025; 30: 2923.","DOI":"10.3390\/molecules30142923"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Adeva M, Gonz\u00e1lez-Luc\u00e1n M, Seco M, Donapetry C. Enzymes involved in l-lactate metabolism in humans. Mitochondrion. 2013; 13: 615\u2013629.","DOI":"10.1016\/j.mito.2013.08.011"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Klein R, Nagy O, T\u00f3thov\u00e1 C, Chovanov\u00e1 F. Clinical and Diagnostic Significance of Lactate Dehydrogenase and Its Isoenzymes in Animals. Veterinary Medicine International. 2020; 2020: 5346483.","DOI":"10.1155\/2020\/5346483"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Zhou Y, Qi M, Yang M. Current Status and Future Perspectives of Lactate Dehydrogenase Detection and Medical Implications: A Review. Biosensors. 2022; 12: 1145.","DOI":"10.3390\/bios12121145"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Pan W, Tao C, Wu Y, Jiang F. A Medicinal Chemistry Perspective on Lactate Dehydrogenase: Current Status and Future Directions. Journal of Medicinal Chemistry. 2025; 68: 16869\u201316900.","DOI":"10.1021\/acs.jmedchem.5c00182"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Miao P, Sheng S, Sun X, Liu J, Huang G. Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life. 2013; 65: 904\u2013910.","DOI":"10.1002\/iub.1216"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood. 2005; 106: 4034\u20134042.","DOI":"10.1182\/blood-2005-04-1622"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Read JA, Winter VJ, Eszes CM, Sessions RB, Brady RL. Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins. 2001; 43: 175\u2013185. <175::aid-prot1029>3.0.co;2-#","DOI":"10.1002\/1097-0134(20010501)43:2"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Chen M, Song Y, Zhang S, Zhang Y, Chen X, Zhang M, et al. Molecular architecture of mammalian pyruvate dehydrogenase complex. Protein & Cell. 2025; 16: 72\u201378.","DOI":"10.1093\/procel\/pwae044"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Zhou ZH, McCarthy DB, O'Connor CM, Reed LJ, Stoops JK. The remarkable structural and functional organization of the eukaryotic pyruvate dehydrogenase complexes. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98: 14802\u201314807.","DOI":"10.1073\/pnas.011597698"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Stacpoole PW, McCall CE. The pyruvate dehydrogenase complex: Life's essential, vulnerable and druggable energy homeostat. Mitochondrion. 2023; 70: 59\u2013102.","DOI":"10.1016\/j.mito.2023.02.007"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Wieland OH. The mammalian pyruvate dehydrogenase complex: structure and regulation. Reviews of Physiology, Biochemistry and Pharmacology. 1983; 96: 123\u2013170.","DOI":"10.1007\/BFb0031008"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Yeaman SJ, Hutcheson ET, Roche TE, Pettit FH, Brown JR, Reed LJ, et al. Sites of phosphorylation on pyruvate dehydrogenase from bovine kidney and heart. Biochemistry. 1978; 17: 2364\u20132370.","DOI":"10.1021\/bi00605a017"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Wang Z, Iwasaki Y, Zhao LF, Nishiyama M, Taguchi T, Tsugita M, et al. Hormonal regulation of glycolytic enzyme gene and pyruvate dehydrogenase kinase\/phosphatase gene transcription. Endocrine Journal. 2009; 56: 1019\u20131030.","DOI":"10.1507\/endocrj.k09e-178"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Harris RA, Bowker-Kinley MM, Huang B, Wu P. Regulation of the activity of the pyruvate dehydrogenase complex. Advances in Enzyme Regulation. 2002; 42: 249\u2013259.","DOI":"10.1016\/s0065-2571(01)00061-9"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Jeon JH, Thoudam T, Choi EJ, Kim MJ, Harris RA, Lee IK. Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: Therapeutic targets in metabolic diseases. Journal of Diabetes Investigation. 2021; 12: 21\u201331.","DOI":"10.1111\/jdi.13345"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Zhou H, Wen Y, Ding H. Pyruvate dehydrogenase complex deficiency masked by septic shock-induced lactic acidosis: a case report. The Journal of International Medical Research. 2024; 52: 3000605241252112.","DOI":"10.1177\/03000605241252112"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Nayak MK, Dhanesha N, Doddapattar P, Rodriguez O, Sonkar VK, Dayal S, et al. Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis. Blood Advances. 2018; 2: 2029\u20132038.","DOI":"10.1182\/bloodadvances.2018022392"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Li Y, Xie Z, Lei X, Yang X, Huang S, Yuan W, et al. Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities. Bioorganic Chemistry. 2024; 144: 107160.","DOI":"10.1016\/j.bioorg.2024.107160"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Goward CR, Nicholls DJ. Malate dehydrogenase: a model for structure, evolution, and catalysis. Protein Science : a Publication of the Protein Society. 1994; 3: 1883\u20131888.","DOI":"10.1002\/pro.5560031027"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Guo D, He H, Meng Y, Luo S, Lu Z. Determiners of cell fates: the tricarboxylic acid cycle versus the citrate-malate shuttle. Protein & Cell. 2023; 14: 162\u2013164.","DOI":"10.1093\/procel\/pwac026"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Molini\u00e9 T, Cougouilles E, David C, Cahoreau E, Portais JC, Mourier A. MDH2 produced OAA is a metabolic switch rewiring the fuelling of respiratory chain and TCA cycle. Biochimica et Biophysica Acta. Bioenergetics. 2022; 1863: 148532.","DOI":"10.1016\/j.bbabio.2022.148532"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Borst P. The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway. IUBMB Life. 2020; 72: 2241\u20132259.","DOI":"10.1002\/iub.2367"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Abbrescia DI, La Piana G, Lofrumento NE. Malate-aspartate shuttle and exogenous NADH\/cytochrome c electron transport pathway as two independent cytosolic reducing equivalent transfer systems. Archives of Biochemistry and Biophysics. 2012; 518: 157\u2013163.","DOI":"10.1016\/j.abb.2011.12.021"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Broeks MH, Meijer NWF, Westland D, Bosma M, Gerrits J, German HM, et al. The malate-aspartate shuttle is important for de novo serine biosynthesis. Cell Reports. 2023; 42: 113043.","DOI":"10.1016\/j.celrep.2023.113043"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Martinez-Vaz BM, Howard AL, Jamburuthugoda VK, Callahan KP. Insights into the regulation of malate dehydrogenase: inhibitors, activators, and allosteric modulation by small molecules. Essays in Biochemistry. 2024; 68: 173\u2013181.","DOI":"10.1042\/EBC20230087"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Provost JJ, Parente AD, Slade KM, Wiese TJ. Exploring the uncharted territory of the potential protein-protein interactions of cytosolic malate dehydrogenase. Essays in Biochemistry. 2024; 68: 83\u201397.","DOI":"10.1042\/EBC20230083"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Kuhn ML, Rakus JF, Quenet D. Acetylation, ADP-ribosylation and methylation of malate dehydrogenase. Essays in Biochemistry. 2024; 68: 199\u2013212.","DOI":"10.1042\/EBC20230080"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Zhu Q, Zhou H, Wu L, Lai Z, Geng D, Yang W, et al. O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1. Nature Chemical Biology. 2022; 18: 1087\u20131095.","DOI":"10.1038\/s41589-022-01085-5"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Nuyttens L, Heyerick M, Roes M, Moens E, Van Dender C, Wallaeys C, et al. A crucial role of the malate aspartate shuttle in metabolic reprogramming in TNF-induced SIRS. Frontiers in Immunology. 2025; 16: 1652516.","DOI":"10.3389\/fimmu.2025.1652516"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Gu H, Chen C, Hao X, Su N, Huang D, Zou Y, et al. MDH1-mediated malate-aspartate NADH shuttle maintains the activity levels of fetal liver hematopoietic stem cells. Blood. 2020; 136: 553\u2013571.","DOI":"10.1182\/blood.2019003940"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Lou Y, Lou Y, Cheng Y, Xu B, Chen H, Dai Y. Panoramic view of MDH1: driving cancer progression and shaping the tumor immune microenvironment. Frontiers in Immunology. 2025; 16: 1631449.","DOI":"10.3389\/fimmu.2025.1631449"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Koch J, Broeks MH, Gautschi M, Jans J, Laemmle A. Inborn errors of the malate aspartate shuttle - Update on patients and cellular models. Molecular Genetics and Metabolism. 2024; 142: 108520.","DOI":"10.1016\/j.ymgme.2024.108520"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Parente AD, Bolland DE, Huisinga KL, Provost JJ. Physiology of malate dehydrogenase and how dysregulation leads to disease. Essays in Biochemistry. 2024; 68: 121\u2013134.","DOI":"10.1042\/EBC20230085"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Yang H, Ye D, Guan KL, Xiong Y. IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2012; 18: 5562\u20135571.","DOI":"10.1158\/1078-0432.CCR-12-1773"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Carosi F, Broseghini E, Fabbri L, Corradi G, Gili R, Forte V, et al. Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives. Cancers. 2024; 16: 2752.","DOI":"10.3390\/cancers16152752"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Avellaneda Matteo D, Grunseth AJ, Gonzalez ER, Anselmo SL, Kennedy MA, Moman P, et al. Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency. The Journal of Biological Chemistry. 2017; 292: 7971\u20137983.","DOI":"10.1074\/jbc.M117.776179"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Xu X, Zhao J, Xu Z, Peng B, Huang Q, Arnold E, et al. Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. The Journal of Biological Chemistry. 2004; 279: 33946\u201333957.","DOI":"10.1074\/jbc.M404298200"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Xu Y, Liu L, Nakamura A, Someya S, Miyakawa T, Tanokura M. Studies on the regulatory mechanism of isocitrate dehydrogenase 2 using acetylation mimics. Scientific Reports. 2017; 7: 9785.","DOI":"10.1038\/s41598-017-10337-7"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Wise DR, Ward PS, Shay JES, Cross JR, Gruber JJ, Sachdeva UM, et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of \u03b1-ketoglutarate to citrate to support cell growth and viability. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108: 19611\u201319616.","DOI":"10.1073\/pnas.1117773108"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Chen X, Sun P, Liu Y, Shen S, Ma T, Ding J. Structures of a constitutively active mutant of human IDH3 reveal new insights into the mechanisms of allosteric activation and the catalytic reaction. The Journal of Biological Chemistry. 2022; 298: 102695.","DOI":"10.1016\/j.jbc.2022.102695"},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"Chandel NS. NADPH-The Forgotten Reducing Equivalent. Cold Spring Harbor Perspectives in Biology. 2021; 13: a040550.","DOI":"10.1101\/cshperspect.a040550"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Zhu S, Huang J, Xu R, Wang Y, Wan Y, McNeel R, et al. Isocitrate dehydrogenase 3b is required for spermiogenesis but dispensable for retinal viability. The Journal of Biological Chemistry. 2022; 298: 102387.","DOI":"10.1016\/j.jbc.2022.102387"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Pirozzi CJ, Yan H. The implications of IDH mutations for cancer development and therapy. Nature Reviews. Clinical Oncology. 2021; 18: 645\u2013661.","DOI":"10.1038\/s41571-021-00521-0"},{"key":"ref119","doi-asserted-by":"publisher","unstructured":"Shen D, Zhang J, Yuan K, Zhao J, Zhao Z, Cui L, et al. Landscape of IDH1\/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis. Molecular Genetics & Genomic Medicine. 2021; 9: e1697.","DOI":"10.1002\/mgg3.1697"},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"Lanman TA, Youssef G, Huang R, Rahman R, DeSalvo M, Flood T, et al. Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes. Neuro-oncology Advances. 2024; 7: vdae227.","DOI":"10.1093\/noajnl\/vdae227"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"DiNardo CD, Venugopal S, Lachowiez C, Takahashi K, Loghavi S, Montalban-Bravo G, et al. Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome. Blood Advances. 2023; 7: 2378\u20132387.","DOI":"10.1182\/bloodadvances.2022008378"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"Abou Dalle I, DiNardo CD. The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia. Therapeutic Advances in Hematology. 2018; 9: 163\u2013173.","DOI":"10.1177\/2040620718777467"},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"Dore MP, Parodi G, Portoghese M, Pes GM. The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review. Oxidative Medicine and Cellular Longevity. 2021; 2021: 5529256.","DOI":"10.1155\/2021\/5529256"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phosphate pathway in health and disease. Nature Metabolism. 2023; 5: 1275\u20131289.","DOI":"10.1038\/s42255-023-00863-2"},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"Au SW, Gover S, Lam VM, Adams MJ. Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency. Structure (London, England : 1993). 2000; 8: 293\u2013303.","DOI":"10.1016\/s0969-2126(00)00104-0"},{"key":"ref126","unstructured":"Hilf R, Ickowicz R, Bartley JC, Abraham S. Multiple molecular forms of glucose-6-phosphate dehydrogenase in normal, preneoplastic, and neoplastic mammary tissues of mice. Cancer Research. 1975; 35: 2109\u20132116."},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Dringen R, Hoepken HH, Minich T, Ruedig C. 1.3 Pentose Phosphate Pathway and NADPH Metabolism. In Lajtha A, Gibson GE, Dienel GA (eds.) Handbook of Neurochemistry and Molecular Neurobiology: Brain Energetics. Integration of Molecular and Cellular Processes (pp. 41\u201362). Springer US: Boston, MA. 2007.","DOI":"10.1007\/978-0-387-30411-3_3"},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Ali EW, Ahmed EEM. The role of erythrocyte enzyme glucose-6-phosphate dehydrogenase (G6PD) deficiency in the pathogenesis of anemia in patients on hemodialysis. Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2013; 24: 1153\u20131156.","DOI":"10.4103\/1319-2442.121271"},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"Giardino G, Cicalese MP, Delmonte O, Migliavacca M, Palterer B, Loffredo L, et al. NADPH Oxidase Deficiency: A Multisystem Approach. Oxidative Medicine and Cellular Longevity. 2017; 2017: 4590127.","DOI":"10.1155\/2017\/4590127"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Shen C, Li W, Wang Y. Research on the oncogenic role of the house-keeping gene GAPDH in human tumors. Translational Cancer Research. 2023; 12: 525\u2013535.","DOI":"10.21037\/tcr-22-1972"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"El Sayed SM. Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article). OncoTargets and Therapy. 2023; 16: 143\u2013155.","DOI":"10.2147\/OTT.S397593"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"Tommasini-Ghelfi S, Murnan K, Kouri FM, Mahajan AS, May JL, Stegh AH. Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease. Science Advances. 2019; 5: eaaw4543.","DOI":"10.1126\/sciadv.aaw4543"},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A, Cheah FC. Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity. Frontiers in Pediatrics. 2022; 10: 875877.","DOI":"10.3389\/fped.2022.875877"},{"key":"ref134","doi-asserted-by":"publisher","unstructured":"Lan T, Arastu S, Lam J, Kim H, Wang W, Wang S, et al. Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer. Nature Communications. 2024; 15: 5857.","DOI":"10.1038\/s41467-024-50157-8"},{"key":"ref135","doi-asserted-by":"publisher","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science (New York, N.Y.). 2020; 368: eaaw5473.","DOI":"10.1126\/science.aaw5473"},{"key":"ref136","doi-asserted-by":"publisher","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Science Advances. 2016; 2: e1600200.","DOI":"10.1126\/sciadv.1600200"},{"key":"ref137","doi-asserted-by":"publisher","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (New York, N.Y.). 2009; 324: 1029\u20131033.","DOI":"10.1126\/science.1160809"},{"key":"ref138","doi-asserted-by":"publisher","unstructured":"Lyu S, Gildor N, Zhang Q, Liao C. Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics. Science China. Life Sciences. 2025; 68: 3281\u20133302.","DOI":"10.1007\/s11427-025-2979-3"},{"key":"ref139","doi-asserted-by":"publisher","unstructured":"Navas LE, Carnero A. NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduction and Targeted Therapy. 2021; 6: 2.","DOI":"10.1038\/s41392-020-00354-w"},{"key":"ref140","doi-asserted-by":"crossref","unstructured":"Chen L, Zhang Z, Hoshino A, Zheng HD, Morley M, Arany Z, et al. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nature Metabolism. 2019; 1: 404\u2013415.","DOI":"10.1038\/s42255-019-0043-x"},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Cai X, Ng CP, Jones O, Fung TS, Ryu KW, Li D, et al. Lactate activates the mitochondrial electron transport chain independently of its metabolism. Molecular Cell. 2023; 83: 3904\u20133920.e7.","DOI":"10.1016\/j.molcel.2023.09.034"},{"key":"ref142","doi-asserted-by":"publisher","unstructured":"Barba I, Carrillo-Bosch L, Seoane J. Targeting the Warburg Effect in Cancer: Where Do We Stand? International Journal of Molecular Sciences. 2024; 25: 3142.","DOI":"10.3390\/ijms25063142"},{"key":"ref143","doi-asserted-by":"publisher","unstructured":"Valvona CJ, Fillmore HL, Nunn PB, Pilkington GJ. The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor. Brain Pathology (Zurich, Switzerland). 2016; 26: 3\u201317.","DOI":"10.1111\/bpa.12299"},{"key":"ref144","doi-asserted-by":"publisher","unstructured":"Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. The Journal of Clinical Investigation. 2013; 123: 3685\u20133692.","DOI":"10.1172\/JCI69741"},{"key":"ref145","doi-asserted-by":"publisher","unstructured":"Mendes C, Serpa J. Revisiting lactate dynamics in cancer-a metabolic expertise or an alternative attempt to survive? Journal of Molecular Medicine (Berlin, Germany). 2020; 98: 1397\u20131414.","DOI":"10.1007\/s00109-020-01965-0"},{"key":"ref146","doi-asserted-by":"publisher","unstructured":"Hensley CT, Faubert B, Yuan Q, Lev-Cohain N, Jin E, Kim J, et al. Metabolic Heterogeneity in Human Lung Tumors. Cell. 2016; 164: 681\u2013694.","DOI":"10.1016\/j.cell.2015.12.034"},{"key":"ref147","doi-asserted-by":"publisher","unstructured":"Hui S, Ghergurovich JM, Morscher RJ, Jang C, Teng X, Lu W, et al. Glucose feeds the TCA cycle via circulating lactate. Nature. 2017; 551: 115\u2013118.","DOI":"10.1038\/nature24057"},{"key":"ref148","doi-asserted-by":"publisher","unstructured":"Chen S, Xu Y, Zhuo W, Zhang L. The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Letters. 2024; 590: 216837.","DOI":"10.1016\/j.canlet.2024.216837"},{"key":"ref149","doi-asserted-by":"publisher","unstructured":"Wang ZH, Peng WB, Zhang P, Yang XP, Zhou Q. Lactate in the tumour microenvironment: From immune modulation to therapy. EBioMedicine. 2021; 73: 103627.","DOI":"10.1016\/j.ebiom.2021.103627"},{"key":"ref150","doi-asserted-by":"publisher","unstructured":"Stoddard BL, Dean A, Koshland DE Jr. Structure of isocitrate dehydrogenase with isocitrate, nicotinamide adenine dinucleotide phosphate, and calcium at 2.5-A resolution: a pseudo-Michaelis ternary complex. Biochemistry. 1993; 32: 9310\u20139316.","DOI":"10.1021\/bi00087a008"},{"key":"ref151","doi-asserted-by":"publisher","unstructured":"Waitkus MS, Yan H. Targeting Isocitrate Dehydrogenase Mutations in Cancer: Emerging Evidence and Diverging Strategies. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2021; 27: 383\u2013388.","DOI":"10.1158\/1078-0432.CCR-20-1827"},{"key":"ref152","doi-asserted-by":"publisher","unstructured":"Waitkus MS, Diplas BH, Yan H. Biological Role and Therapeutic Potential of IDH Mutations in Cancer. Cancer Cell. 2018; 34: 186\u2013195.","DOI":"10.1016\/j.ccell.2018.04.011"},{"key":"ref153","doi-asserted-by":"publisher","unstructured":"Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009; 462: 739\u2013744.","DOI":"10.1038\/nature08617"},{"key":"ref154","doi-asserted-by":"publisher","unstructured":"Liu Y, Wang M, Guo Y, Wang L, Guo W. D-2-hydroxyglutarate dehydrogenase governs adult neural stem cell activation and promotes histone acetylation via ATP-citrate lyase. Cell Reports. 2023; 42: 112067.","DOI":"10.1016\/j.celrep.2023.112067"},{"key":"ref155","doi-asserted-by":"publisher","unstructured":"Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011; 19: 17\u201330.","DOI":"10.1016\/j.ccr.2010.12.014"},{"key":"ref156","doi-asserted-by":"publisher","unstructured":"Ye D, Guan KL, Xiong Y. Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates. Trends in Cancer. 2018; 4: 151\u2013165.","DOI":"10.1016\/j.trecan.2017.12.005"},{"key":"ref157","doi-asserted-by":"publisher","unstructured":"Sarkar S, Chang CI, Jean J, Wu MJ. TCA cycle-derived oncometabolites in cancer and the immune microenvironment. Journal of Biomedical Science. 2025; 32: 87.","DOI":"10.1186\/s12929-025-01186-y"},{"key":"ref158","doi-asserted-by":"publisher","unstructured":"Choate KA, Pratt EPS, Jennings MJ, Winn RJ, Mann PB. IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications. Biology. 2024; 13: 885.","DOI":"10.3390\/biology13110885"},{"key":"ref159","doi-asserted-by":"publisher","unstructured":"Zimmer AD, Walbrecq G, Kozar I, Behrmann I, Haan C. Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells. Hypoxia (Auckland, N.Z.). 2016; 4: 135\u2013145.","DOI":"10.2147\/HP.S99044"},{"key":"ref160","doi-asserted-by":"publisher","unstructured":"Tao S, Tao K, Cai X. Pan-cancer analysis reveals PDK family as potential indicators related to prognosis and immune infiltration. Scientific Reports. 2024; 14: 5665.","DOI":"10.1038\/s41598-024-55455-1"},{"key":"ref161","doi-asserted-by":"publisher","unstructured":"Rajagopalan KN, Egnatchik RA, Calvaruso MA, Wasti AT, Padanad MS, Boroughs LK, et al. Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells. Cancer & Metabolism. 2015; 3: 7.","DOI":"10.1186\/s40170-015-0134-4"},{"key":"ref162","doi-asserted-by":"publisher","unstructured":"Constantin-Teodosiu D. Regulation of muscle pyruvate dehydrogenase complex in insulin resistance: effects of exercise and dichloroacetate. Diabetes & Metabolism Journal. 2013; 37: 301\u2013314.","DOI":"10.4093\/dmj.2013.37.5.301"},{"key":"ref163","doi-asserted-by":"publisher","unstructured":"Yue J, Xu J, Yin Y, Shu Y, Li Y, Li T, et al. Targeting the PDK\/PDH axis to reverse metabolic abnormalities by structure-based virtual screening with in vitro and in vivo experiments. International Journal of Biological Macromolecules. 2024; 262: 129970.","DOI":"10.1016\/j.ijbiomac.2024.129970"},{"key":"ref164","doi-asserted-by":"publisher","unstructured":"Wang X, Shen X, Yan Y, Li H. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications. Bioscience Reports. 2021; 41: BSR20204402.","DOI":"10.1042\/BSR20204402"},{"key":"ref165","doi-asserted-by":"publisher","unstructured":"Stacpoole PW. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex\/Pyruvate Dehydrogenase Kinase (PDC\/PDK) Axis in Cancer. Journal of the National Cancer Institute. 2017; 109:  https:\/\/doi.org\/10.1093\/jnci\/djx071","DOI":"10.1093\/jnci\/djx071"},{"key":"ref166","doi-asserted-by":"publisher","unstructured":"Ju HQ, Lin JF, Tian T, Xie D, Xu RH. NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications. Signal Transduction and Targeted Therapy. 2020; 5: 231.","DOI":"10.1038\/s41392-020-00326-0"},{"key":"ref167","doi-asserted-by":"publisher","unstructured":"Niu X, Stancliffe E, Gelman SJ, Wang L, Schwaiger-Haber M, Rowles JL 3rd, et al. Cytosolic and mitochondrial NADPH fluxes are independently regulated. Nature Chemical Biology. 2023; 19: 837\u2013845.","DOI":"10.1038\/s41589-023-01283-9"},{"key":"ref168","doi-asserted-by":"publisher","unstructured":"Simmen FA, Alhallak I, Simmen RCM. Malic enzyme 1 (ME1) in the biology of cancer: it is not just intermediary metabolism. Journal of Molecular Endocrinology. 2020; 65: R77\u2013R90.","DOI":"10.1530\/jme-20-0176"},{"key":"ref169","doi-asserted-by":"publisher","unstructured":"Mondal A, Mukherjee S, Upadhyay P, Saxena I, Pati S, Singh S. Enhancing NADPH to restore redox homeostasis and lysosomal function in G6PD-deficient microglia. Heliyon. 2025; 11: e42735.","DOI":"10.1016\/j.heliyon.2025.e42735"},{"key":"ref170","doi-asserted-by":"publisher","unstructured":"Choudhury FK. Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression. Antioxidants (Basel, Switzerland). 2021; 10: 1838.","DOI":"10.3390\/antiox10111838"},{"key":"ref171","doi-asserted-by":"publisher","unstructured":"Liu S, Sun Y, Jiang M, Li Y, Tian Y, Xue W, et al. Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase. Hepatology (Baltimore, Md.). 2017; 66: 631\u2013645.","DOI":"10.1002\/hep.29202"},{"key":"ref172","doi-asserted-by":"publisher","unstructured":"Diehl FF, Lewis CA, Fiske BP, Vander Heiden MG. Cellular redox state constrains serine synthesis and nucleotide production to impact cell proliferation. Nature Metabolism. 2019; 1: 861\u2013867.","DOI":"10.1038\/s42255-019-0108-x"},{"key":"ref173","doi-asserted-by":"publisher","unstructured":"Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Molecular Medicine (Cambridge, Mass.). 2024; 30: 279.","DOI":"10.1186\/s10020-024-01019-y"},{"key":"ref174","doi-asserted-by":"publisher","unstructured":"Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, et al. Metabolic syndrome. Nature Reviews. Disease Primers. 2024; 10: 77.","DOI":"10.1038\/s41572-024-00563-5"},{"key":"ref175","doi-asserted-by":"publisher","unstructured":"Lee IK. The role of pyruvate dehydrogenase kinase in diabetes and obesity. Diabetes & Metabolism Journal. 2014; 38: 181\u2013186.","DOI":"10.4093\/dmj.2014.38.3.181"},{"key":"ref176","doi-asserted-by":"publisher","unstructured":"Godesi S, Han JR, Kim JK, Kwak DI, Lee J, Nada H, et al. Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment. Pharmaceuticals (Basel, Switzerland). 2023; 16: 683.","DOI":"10.3390\/ph16050683"},{"key":"ref177","doi-asserted-by":"publisher","unstructured":"Sergi D, Naumovski N, Heilbronn LK, Abeywardena M, O'Callaghan N, Lionetti L, et al. Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet. Frontiers in Physiology. 2019; 10: 532.","DOI":"10.3389\/fphys.2019.00532"},{"key":"ref178","doi-asserted-by":"publisher","unstructured":"Holness MJ, Kraus A, Harris RA, Sugden MC. Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes. 2000; 49: 775\u2013781.","DOI":"10.2337\/diabetes.49.5.775"},{"key":"ref179","doi-asserted-by":"publisher","unstructured":"Thoudam T, Ha CM, Leem J, Chanda D, Park JS, Kim HJ, et al. PDK4 Augments ER-Mitochondria Contact to Dampen Skeletal Muscle Insulin Signaling During Obesity. Diabetes. 2019; 68: 571\u2013586.","DOI":"10.2337\/db18-0363"},{"key":"ref180","doi-asserted-by":"publisher","unstructured":"Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, Harris RA. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes. 1999; 48: 1593\u20131599.","DOI":"10.2337\/diabetes.48.8.1593"},{"key":"ref181","doi-asserted-by":"publisher","unstructured":"Kanazawa K, Uchino H, Shigiyama F, Igarashi H, Ikehara K, Yoshikawa F, et al. Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium-glucose cotransporter 2 inhibitor: A randomized, open-label, prospective study. Journal of Diabetes Investigation. 2019; 10: 1022\u20131031.","DOI":"10.1111\/jdi.12994"},{"key":"ref182","doi-asserted-by":"publisher","unstructured":"Challa AA. The enduring relevance of the Randle cycle. Nature Reviews. Endocrinology. 2025; 21: 269.","DOI":"10.1038\/s41574-025-01092-1"},{"key":"ref183","doi-asserted-by":"publisher","unstructured":"Burdick J, Sun Z. Pyruvate Dehydrogenase Kinase 4: A Key Mediator for Metabolic Regulation of Liver Regeneration. Hepatology Communications. 2020; 4: 475\u2013477.","DOI":"10.1002\/hep4.1506"},{"key":"ref184","doi-asserted-by":"publisher","unstructured":"Zhao G, Jeoung NH, Burgess SC, Rosaaen-Stowe KA, Inagaki T, Latif S, et al. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology. 2008; 294: H936\u2013H943.","DOI":"10.1152\/ajpheart.00870.2007"},{"key":"ref185","doi-asserted-by":"publisher","unstructured":"Du X, Matsumura T, Edelstein D, Rossetti L, Zsengell\u00e9r Z, Szab\u00f3 C, et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. The Journal of Clinical Investigation. 2003; 112: 1049\u20131057.","DOI":"10.1172\/JCI18127"},{"key":"ref186","doi-asserted-by":"publisher","unstructured":"Glover MR, Davies MJ, Fuentes-Lemus E. Oxidation of the active site cysteine residue of glyceraldehyde-3-phosphate dehydrogenase to the hyper-oxidized sulfonic acid form is favored under crowded conditions. Free Radical Biology & Medicine. 2024; 212: 1\u20139.","DOI":"10.1016\/j.freeradbiomed.2023.12.015"},{"key":"ref187","doi-asserted-by":"publisher","unstructured":"Gan L, Du X, Wei Y, Hu Z. Sources of advanced glycation end products in the human body: a mini review. International Journal of Food Science and Technology. 2025; 60: vvaf119.","DOI":"10.1093\/ijfood\/vvaf119"},{"key":"ref188","doi-asserted-by":"publisher","unstructured":"Sofronova AA, Pozdyshev DV, Barinova KV, Muronetz VI, Semenyuk PI. Glycation of glyceraldehyde-3-phosphate dehydrogenase inhibits the binding with \u03b1-synuclein and RNA. Archives of Biochemistry and Biophysics. 2021; 698: 108744.","DOI":"10.1016\/j.abb.2020.108744"},{"key":"ref189","doi-asserted-by":"publisher","unstructured":"Barinova KV, Serebryakova MV, Melnikova AK, Medvedeva MV, Muronetz VI, Schmalhausen EV. Mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in the presence of methylglyoxal. Archives of Biochemistry and Biophysics. 2023; 733: 109485.","DOI":"10.1016\/j.abb.2022.109485"},{"key":"ref190","doi-asserted-by":"publisher","unstructured":"Iacobini C, Vitale M, Pesce C, Pugliese G, Menini S. Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future. Antioxidants (Basel, Switzerland). 2021; 10: 727.","DOI":"10.3390\/antiox10050727"},{"key":"ref191","doi-asserted-by":"publisher","unstructured":"Ham M, Choe SS, Shin KC, Choi G, Kim JW, Noh JR, et al. Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity. Diabetes. 2016; 65: 2624\u20132638.","DOI":"10.2337\/db16-0060"},{"key":"ref192","doi-asserted-by":"publisher","unstructured":"Errigo A, Dore MP, Merola E, Pes GM. Glucose-6-Phosphate Dehydrogenase Deficiency and Cardiovascular Risk in Familial Hypercholesterolemia: A Retrospective Cohort Study. Lipidology. 2025; 2: 22.","DOI":"10.3390\/lipidology2040022"},{"key":"ref193","doi-asserted-by":"publisher","unstructured":"Thomas JE, Kang S, Wyatt CJ, Kim FS, Mangelsdorff AD, Weigel FK. Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers. Texas Heart Institute Journal. 2018; 45: 144\u2013150.","DOI":"10.14503\/THIJ-16-6052"},{"key":"ref194","doi-asserted-by":"publisher","unstructured":"Pes GM, Parodi G, Dore MP. Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: A propensity score-matched study. Atherosclerosis. 2019; 282: 148\u2013153.","DOI":"10.1016\/j.atherosclerosis.2019.01.027"},{"key":"ref195","doi-asserted-by":"publisher","unstructured":"Ou Z, Chen Y, Li J, Ouyang F, Liu G, Tan S, et al. Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes. Neurology. 2020; 95: e1471\u2013e1478.","DOI":"10.1212\/WNL.0000000000010245"},{"key":"ref196","doi-asserted-by":"publisher","unstructured":"Fojas EG, Lessan N, Chiong MA, Naemi R. Association of glucose-6-phosphate dehydrogenase (G6PD) expression and obesity: A systematized review. Obesity Medicine. 2024; 48: 100546.","DOI":"10.1016\/j.obmed.2024.100546"},{"key":"ref197","doi-asserted-by":"publisher","unstructured":"Ham M, Lee JW, Choi AH, Jang H, Choi G, Park J, et al. Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress. Molecular and Cellular Biology. 2013; 33: 2425\u20132435.","DOI":"10.1128\/MCB.01260-12"},{"key":"ref198","doi-asserted-by":"publisher","unstructured":"Lee-Young RS, Hoffman NJ, Murphy KT, Henstridge DC, Samocha-Bonet D, Siebel AL, et al. Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle. Molecular Metabolism. 2016; 5: 1083\u20131091.","DOI":"10.1016\/j.molmet.2016.09.002"},{"key":"ref199","doi-asserted-by":"publisher","unstructured":"Schneider AM, Rawat D, Weinstein LS, Gupte SA, Richards WO. Effects of laparoscopic Roux-en-Y gastric bypass on glucose-6 phosphate dehydrogenase activity in obese type 2 diabetics. Surgical Endoscopy. 2012; 26: 823\u2013830.","DOI":"10.1007\/s00464-011-1959-8"},{"key":"ref200","doi-asserted-by":"publisher","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. Signal Transduction and Targeted Therapy. 2022; 7: 305.","DOI":"10.1038\/s41392-022-01151-3"},{"key":"ref201","doi-asserted-by":"publisher","unstructured":"Feng T, Zhao X, Gu P, Yang W, Wang C, Guo Q, et al. Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2. Nature Communications. 2022; 13: 5208.","DOI":"10.1038\/s41467-022-32871-3"},{"key":"ref202","doi-asserted-by":"publisher","unstructured":"Gaster M. Reduced TCA Flux in Diabetic Myotubes: Determined by Single Defects? Biochemistry Research International. 2012; 2012: 716056.","DOI":"10.1155\/2012\/716056"},{"key":"ref203","doi-asserted-by":"publisher","unstructured":"Friedman JE, Caro JF, Pories WJ, Azevedo JL Jr, Dohm GL. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. Metabolism: Clinical and Experimental. 1994; 43: 1047\u20131054.","DOI":"10.1016\/0026-0495(94)90188-0"},{"key":"ref204","doi-asserted-by":"publisher","unstructured":"Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. The Journal of Biological Chemistry. 2009; 284: 2811\u20132822.","DOI":"10.1074\/jbc.M806409200"},{"key":"ref205","doi-asserted-by":"publisher","unstructured":"Su Z, Nie Y, Huang X, Zhu Y, Feng B, Tang L, et al. Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns. Frontiers in Pharmacology. 2019; 10: 1193.","DOI":"10.3389\/fphar.2019.01193"},{"key":"ref206","doi-asserted-by":"publisher","unstructured":"Maschari D, Saxena G, Law TD, Walsh E, Campbell MC, Consitt LA. Lactate-induced lactylation in skeletal muscle is associated with insulin resistance in humans. Frontiers in Physiology. 2022; 13: 951390.","DOI":"10.3389\/fphys.2022.951390"},{"key":"ref207","doi-asserted-by":"publisher","unstructured":"Lee WD, Weilandt DR, Liang L, MacArthur MR, Jaiswal N, Ong O, et al. Lactate homeostasis is maintained through regulation of glycolysis and lipolysis. Cell Metabolism. 2025; 37: 758\u2013771.e8.","DOI":"10.1016\/j.cmet.2024.12.009"},{"key":"ref208","doi-asserted-by":"publisher","unstructured":"Chen G, Liu J, Guo Y, Sun P. Mechanisms for Regulatory Effects of Exercise on Metabolic Diseases from the Lactate-Lactylation Perspective. International Journal of Molecular Sciences. 2025; 26: 3469.","DOI":"10.3390\/ijms26083469"},{"key":"ref209","unstructured":"Scott A. Enzymopathies: Genetic Mutations, Clinical Manifestations, and Diagnostic Innovations. Journal of Molecular Pathology. 2024; 5: 172."},{"key":"ref210","doi-asserted-by":"publisher","unstructured":"Grace RF, Glader B. Red Blood Cell Enzyme Disorders. Pediatric Clinics of North America. 2018; 65: 579\u2013595.","DOI":"10.1016\/j.pcl.2018.02.005"},{"key":"ref211","doi-asserted-by":"crossref","unstructured":"Robinson CR, Boothby AB, Fertrin KY. Red Blood Cell Enzymopathies. In Sokol L, Zhang L (eds.) Non-Neoplastic Hematologic Disorders: A Quick Review of Modern Diagnostic and Therapeutic Approaches (pp. 175\u2013187). Springer Nature Switzerland: Cham. 2024","DOI":"10.1007\/978-3-031-62373-8_13"},{"key":"ref212","doi-asserted-by":"publisher","unstructured":"Khan AA, Allemailem KS, Alhumaydhi FA, Gowder SJT, Rahmani AH. The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism. Endocrine, Metabolic & Immune Disorders Drug Targets. 2020; 20: 855\u2013868.","DOI":"10.2174\/1871530320666191230141110"},{"key":"ref213","doi-asserted-by":"publisher","unstructured":"Harcke SJ, Rizzolo D, Harcke HT. G6PD deficiency: An update. JAAPA : Official Journal of the American Academy of Physician Assistants. 2019; 32: 21\u201326.","DOI":"10.1097\/01.JAA.0000586304.65429.a7"},{"key":"ref214","doi-asserted-by":"publisher","unstructured":"Pengsuk N, Chamchoy K, Duangdee C, Satayarak J, Saralamba N, Nguitragool W, et al. Integrated Phenotypic and Genotypic Approaches for Accurate Diagnosis of G6PD Deficiency: Implications for Drug Safety in Thailand. Pharmacology Research & Perspectives. 2025; 13: e70117.","DOI":"10.1002\/prp2.70117"},{"key":"ref215","doi-asserted-by":"publisher","unstructured":"Yang HC, Wu YH, Liu HY, Stern A, Chiu DTY. What has passed is prolog: new cellular and physiological roles of G6PD. Free Radical Research. 2016; 50: 1047\u20131064.","DOI":"10.1080\/10715762.2016.1223296"},{"key":"ref216","doi-asserted-by":"publisher","unstructured":"M\u00f6ller MN, Orrico F, Villar SF, L\u00f3pez AC, Silva N, Donz\u00e9 M, et al. Oxidants and Antioxidants in the Redox Biochemistry of Human Red Blood Cells. ACS Omega. 2023; 8: 147\u2013168.","DOI":"10.1021\/acsomega.2c06768"},{"key":"ref217","doi-asserted-by":"publisher","unstructured":"Luzzatto L. G6PD deficiency and malaria selection. Heredity. 2012; 108: 456.","DOI":"10.1038\/hdy.2011.90"},{"key":"ref218","doi-asserted-by":"publisher","unstructured":"Jollow DJ, McMillan DC. Oxidative stress, glucose-6-phosphate dehydrogenase and the red cell. Advances in Experimental Medicine and Biology. 2001; 500: 595\u2013605.","DOI":"10.1007\/978-1-4615-0667-6_88"},{"key":"ref219","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Manzo S, Marcial-Quino J, Ortega-Cuellar D, Serrano-Posada H, Gonz\u00e1lez-Valdez A, Vanoye-Carlo A, et al. Functional and Biochemical Analysis of Glucose-6-Phosphate Dehydrogenase (G6PD) Variants: Elucidating the Molecular Basis of G6PD Deficiency. Catalysts. 2017; 7: 135.","DOI":"10.3390\/catal7050135"},{"key":"ref220","unstructured":"Ganetzky R, McCormick EM, Falk MJ. Primary Pyruvate Dehydrogenase Complex Deficiency Overview. In Gene Reviews. University of Washington: Seattle (WA). 1993."},{"key":"ref221","doi-asserted-by":"publisher","unstructured":"Sperl W, Fleuren L, Freisinger P, Haack TB, Ribes A, Feichtinger RG, et al. The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders. Journal of Inherited Metabolic Disease. 2015; 38: 391\u2013403.","DOI":"10.1007\/s10545-014-9787-3"},{"key":"ref222","doi-asserted-by":"publisher","unstructured":"Barnerias C, Saudubray JM, Touati G, De Lonlay P, Dulac O, Ponsot G, et al. Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Developmental Medicine and Child Neurology. 2010; 52: e1\u20139.","DOI":"10.1111\/j.1469-8749.2009.03541.x"},{"key":"ref223","doi-asserted-by":"publisher","unstructured":"Horga A, Woodward CE, Mills A, Pare\u00e9s I, Hargreaves IP, Brown RM, et al. Differential phenotypic expression of a novel PDHA1 mutation in a female monozygotic twin pair. Human Genetics. 2019; 138: 1313\u20131322.","DOI":"10.1007\/s00439-019-02075-9"},{"key":"ref224","doi-asserted-by":"publisher","unstructured":"M\u00fcller J, Radej J, Horak J, Karvunidis T, Valesova L, Kriz M, et al. Lactate: The Fallacy of Oversimplification. Biomedicines. 2023; 11: 3192.","DOI":"10.3390\/biomedicines11123192"},{"key":"ref225","doi-asserted-by":"publisher","unstructured":"Castiglioni C, Verrigni D, Okuma C, Diaz A, Alvarez K, Rizza T, et al. Pyruvate dehydrogenase deficiency presenting as isolated paroxysmal exercise induced dystonia successfully reversed with thiamine supplementation. Case report and mini-review. European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society. 2015; 19: 497\u2013503.","DOI":"10.1016\/j.ejpn.2015.04.008"},{"key":"ref226","doi-asserted-by":"publisher","unstructured":"Bruhn H, Naess K, Ygberg S, Pe\u00f1a-P\u00e9rez L, Lesko N, Wibom R, et al. Novel Synonymous and Deep Intronic Variants Causing Primary and Secondary Pyruvate Dehydrogenase Complex Deficiency. Human Mutation. 2024; 2024: 1611838.","DOI":"10.1155\/2024\/1611838"},{"key":"ref227","doi-asserted-by":"publisher","unstructured":"DeBrosse SD, Okajima K, Zhang S, Nakouzi G, Schmotzer CL, Lusk-Kopp M, et al. Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex (PDC) deficiency: lack of correlation with genotype. Molecular Genetics and Metabolism. 2012; 107: 394\u2013402.","DOI":"10.1016\/j.ymgme.2012.09.001"},{"key":"ref228","doi-asserted-by":"publisher","unstructured":"Wexler ID, Hemalatha SG, McConnell J, Buist NR, Dahl HH, Berry SA, et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology. 1997; 49: 1655\u20131661.","DOI":"10.1212\/wnl.49.6.1655"},{"key":"ref229","doi-asserted-by":"publisher","unstructured":"Schoenmann N, Tannenbaum N, Hodgeman RM, Raju RP. Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2023; 1869: 166769.","DOI":"10.1016\/j.bbadis.2023.166769"},{"key":"ref230","doi-asserted-by":"crossref","unstructured":"Naik P, Prasad S, Cucullo L. Role and Function of Dehydrogenases in CNS and Blood-Brain Barrier Pathophysiology. In Canuto RA (ed.) Dehydrogenases. IntechOpen: London. 2012.","DOI":"10.5772\/48338"},{"key":"ref231","doi-asserted-by":"publisher","unstructured":"Yang HM. Mitochondrial Dysfunction in Neurodegenerative Diseases. Cells. 2025; 14: 276.","DOI":"10.3390\/cells14040276"},{"key":"ref232","doi-asserted-by":"publisher","unstructured":"Revuelto-Rey J, Egea-Guerrero JJ, Mu\u00f1oz-S\u00e1nchez MA, Murillo-Cabezas F. Cerebral microdialysis in the current clinical setting. Medicina Intensiva. 2012; 36: 213\u2013219.","DOI":"10.1016\/j.medin.2011.08.002"},{"key":"ref233","doi-asserted-by":"publisher","unstructured":"Na D, Zhang Z, Meng M, Li M, Gao J, Kong J, et al. Energy Metabolism and Brain Aging: Strategies to Delay Neuronal Degeneration. Cellular and Molecular Neurobiology. 2025; 45: 38.","DOI":"10.1007\/s10571-025-01555-z"},{"key":"ref234","doi-asserted-by":"publisher","unstructured":"Polj\u0161ak B, Kova\u010d V, \u0160palj S, Milisav I. The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ Modulation. International Journal of Molecular Sciences. 2023; 24: 2959.","DOI":"10.3390\/ijms24032959"},{"key":"ref235","doi-asserted-by":"publisher","unstructured":"Gerszon J, Rodacka A. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation. Ageing Research Reviews. 2018; 48: 21\u201331.","DOI":"10.1016\/j.arr.2018.09.003"},{"key":"ref236","doi-asserted-by":"publisher","unstructured":"Nakajima H, Itakura M, Kubo T, Kaneshige A, Harada N, Izawa T, et al. Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Aggregation Causes Mitochondrial Dysfunction during Oxidative Stress-induced Cell Death. The Journal of Biological Chemistry. 2017; 292: 4727\u20134742.","DOI":"10.1074\/jbc.M116.759084"},{"key":"ref237","doi-asserted-by":"publisher","unstructured":"Schmalhausen EV, Medvedeva MV, Muronetz VI. Glyceraldehyde-3-phosphate dehydrogenase is involved in the pathogenesis of Alzheimer's disease. Archives of Biochemistry and Biophysics. 2024; 758: 110065.","DOI":"10.1016\/j.abb.2024.110065"},{"key":"ref238","doi-asserted-by":"publisher","unstructured":"Medvedeva MV, Kleimenov SY, Samygina VR, Muronetz VI, Schmalhausen EV. S-nitrosylation and S-glutathionylation of GAPDH: Similarities, differences, and relationships. Biochimica et Biophysica Acta. General Subjects. 2023; 1867: 130418.","DOI":"10.1016\/j.bbagen.2023.130418"},{"key":"ref239","doi-asserted-by":"publisher","unstructured":"Itakura M, Nakajima H, Kubo T, Semi Y, Kume S, Higashida S, et al. Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-\u03b2 Amyloidogenesis in Alzheimer Disease. The Journal of Biological Chemistry. 2015; 290: 26072\u201326087.","DOI":"10.1074\/jbc.M115.669291"},{"key":"ref240","doi-asserted-by":"publisher","unstructured":"Ping Z, Xiaomu W, Xufang X, Wenfeng C, Liang S, Tao W. GAPDH rs1136666 SNP indicates a high risk of Parkinson's disease. Neuroscience Letters. 2018; 685: 55\u201362.","DOI":"10.1016\/j.neulet.2018.06.011"},{"key":"ref241","doi-asserted-by":"publisher","unstructured":"Rumpf S, Sanal N, Marzano M. Energy metabolic pathways in neuronal development and function. Oxford Open Neuroscience. 2023; 2: kvad004.","DOI":"10.1093\/oons\/kvad004"},{"key":"ref242","doi-asserted-by":"publisher","unstructured":"Steffan D, Pezzini C, Esposito M, Franco-Romero A. Mitochondrial Aging in the CNS: Unravelling Implications for Neurological Health and Disease. Biomolecules. 2025; 15: 1252.","DOI":"10.3390\/biom15091252"},{"key":"ref243","doi-asserted-by":"publisher","unstructured":"Sheu KF, Kim YT, Blass JP, Weksler ME. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Annals of Neurology. 1985; 17: 444\u2013449.","DOI":"10.1002\/ana.410170505"},{"key":"ref244","doi-asserted-by":"publisher","unstructured":"Sang S, Pan X, Chen Z, Zeng F, Pan S, Liu H, et al. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not. Alzheimer's Research & Therapy. 2018; 10: 26.","DOI":"10.1186\/s13195-018-0354-2"},{"key":"ref245","doi-asserted-by":"publisher","unstructured":"Burns JS, Manda G. Metabolic Pathways of the Warburg Effect in Health and Disease: Perspectives of Choice, Chain or Chance. International Journal of Molecular Sciences. 2017; 18: 2755.","DOI":"10.3390\/ijms18122755"},{"key":"ref246","doi-asserted-by":"publisher","unstructured":"Neves A, Costalat R, Pellerin L. Determinants of brain cell metabolic phenotypes and energy substrate utilization unraveled with a modeling approach. PLoS Computational Biology. 2012; 8: e1002686.","DOI":"10.1371\/journal.pcbi.1002686"},{"key":"ref247","doi-asserted-by":"publisher","unstructured":"Mohan GS, Kumar R. Impairment of Tricarboxylic Acid Cycle (TCA) Cycle in Alzheimer's Disease: Mechanisms, Implications, and Potential Therapies. Aging and Disease. 2025; 16: 2553\u20132574.","DOI":"10.14336\/AD.2025.0472"},{"key":"ref248","doi-asserted-by":"publisher","unstructured":"Ma T, Peng Y, Huang W, Liu Y, Ding J. The \u03b2 and \u03b3 subunits play distinct functional roles in the \u03b12\u03b2\u03b3 heterotetramer of human NAD-dependent isocitrate dehydrogenase. Scientific Reports. 2017; 7: 41882.","DOI":"10.1038\/srep41882"},{"key":"ref249","doi-asserted-by":"publisher","unstructured":"May JL, Kouri FM, Hurley LA, Liu J, Tommasini-Ghelfi S, Ji Y, et al. IDH3\u03b1 regulates one-carbon metabolism in glioblastoma. Science Advances. 2019; 5: eaat0456.","DOI":"10.1126\/sciadv.aat0456"},{"key":"ref250","doi-asserted-by":"publisher","unstructured":"Kane DA. Lactate oxidation at the mitochondria: a lactate-malate-aspartate shuttle at work. Frontiers in Neuroscience. 2014; 8: 366.","DOI":"10.3389\/fnins.2014.00366"},{"key":"ref251","doi-asserted-by":"publisher","unstructured":"Mao Z, Liu W, Zou R, Sun L, Huang S, Wu L, et al. Glibenclamide targets MDH2 to relieve aging phenotypes through metabolism-regulated epigenetic modification. Signal Transduction and Targeted Therapy. 2025; 10: 67.","DOI":"10.1038\/s41392-025-02157-3"},{"key":"ref252","doi-asserted-by":"publisher","unstructured":"Sonntag KC, Ryu WI, Amirault KM, Healy RA, Siegel AJ, McPhie DL, et al. Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles. Scientific Reports. 2017; 7: 14038.","DOI":"10.1038\/s41598-017-14420-x"},{"key":"ref253","doi-asserted-by":"publisher","unstructured":"Rademacher K, Nakamura K. Role of dopamine neuron activity in Parkinson's disease pathophysiology. Experimental Neurology. 2024; 373: 114645.","DOI":"10.1016\/j.expneurol.2023.114645"},{"key":"ref254","doi-asserted-by":"publisher","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer's disease: a review. 3 Biotech. 2022; 12: 55.","DOI":"10.1007\/s13205-022-03123-4"},{"key":"ref255","doi-asserted-by":"publisher","unstructured":"McReynolds MR, Chellappa K, Baur JA. Age-related NAD+ decline. Experimental Gerontology. 2020; 134: 110888.","DOI":"10.1016\/j.exger.2020.110888"},{"key":"ref256","doi-asserted-by":"publisher","unstructured":"Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PloS One. 2012; 7: e42357.","DOI":"10.1371\/journal.pone.0042357"},{"key":"ref257","doi-asserted-by":"publisher","unstructured":"Guest J, Grant R, Mori TA, Croft KD. Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age in Cerebrospinal Fluid. PLoS One. 2014; 9: e85335.","DOI":"10.1371\/journal.pone.0085335"},{"key":"ref258","doi-asserted-by":"publisher","unstructured":"Belenky P, Bogan KL, Brenner C. NAD+ metabolism in health and disease. Trends in Biochemical Sciences. 2007; 32: 12\u201319.","DOI":"10.1016\/j.tibs.2006.11.006"},{"key":"ref259","doi-asserted-by":"publisher","unstructured":"Yoshino J, Baur JA, Imai SI. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism. 2018; 27: 513\u2013528.","DOI":"10.1016\/j.cmet.2017.11.002"},{"key":"ref260","doi-asserted-by":"publisher","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, et al. Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications. Acta Pharmaceutica Sinica. B. 2025; 15: 15\u201334.","DOI":"10.1016\/j.apsb.2024.10.004"},{"key":"ref261","doi-asserted-by":"publisher","unstructured":"Jurc\u0103u MC, Andronie-Cioara FL, Jurc\u0103u A, Marcu F, \u0162i\u021b DM, Pa\u0219cal\u0103u N, et al. The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer's Disease: Therapeutic Implications and Future Perspectives. Antioxidants (Basel, Switzerland). 2022; 11: 2167.","DOI":"10.3390\/antiox11112167"},{"key":"ref262","doi-asserted-by":"publisher","unstructured":"Wang CH, Wu SB, Wu YT, Wei YH. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Experimental Biology and Medicine (Maywood, N.J.). 2013; 238: 450\u2013460.","DOI":"10.1177\/1535370213493069"},{"key":"ref263","doi-asserted-by":"publisher","unstructured":"Simpson DSA, Oliver PL. ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease. Antioxidants (Basel, Switzerland). 2020; 9: 743.","DOI":"10.3390\/antiox9080743"},{"key":"ref264","doi-asserted-by":"publisher","unstructured":"Jamerson LE, Bradshaw PC. Effects of aging and anti-aging dietary restriction on regulators of the [NADPH]\/[NADP+] in different neural cell types and brain regions. Free Radical Biology & Medicine. 2025; 240: 745\u2013772.","DOI":"10.1016\/j.freeradbiomed.2025.09.001"},{"key":"ref265","doi-asserted-by":"publisher","unstructured":"Britt EC, Lika J, Giese MA, Schoen TJ, Seim GL, Huang Z, et al. Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils. Nature Metabolism. 2022; 4: 389\u2013403.","DOI":"10.1038\/s42255-022-00550-8"},{"key":"ref266","doi-asserted-by":"publisher","unstructured":"Vorobjeva NV, Chernyak BV. NETosis: Molecular Mechanisms, Role in Physiology and Pathology. Biochemistry. Biokhimiia. 2020; 85: 1178\u20131190.","DOI":"10.1134\/S0006297920100065"},{"key":"ref267","doi-asserted-by":"publisher","unstructured":"Siler U, Romao S, Tejera E, Pastukhov O, Kuzmenko E, Valencia RG, et al. Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis. The Journal of Allergy and Clinical Immunology. 2017; 139: 212\u2013219.e3.","DOI":"10.1016\/j.jaci.2016.04.041"},{"key":"ref268","doi-asserted-by":"publisher","unstructured":"Pearce EL. Metabolism in T cell activation and differentiation. Current Opinion in Immunology. 2010; 22: 314\u2013320.","DOI":"10.1016\/j.coi.2010.01.018"},{"key":"ref269","doi-asserted-by":"publisher","unstructured":"van der Windt GJW, Pearce EL. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunological Reviews. 2012; 249: 27\u201342.","DOI":"10.1111\/j.1600-065X.2012.01150.x"},{"key":"ref270","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xu Y, Lu W, Ghergurovich JM, Guo L, Blair IA, et al. Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation. Cell Metabolism. 2021; 33: 94\u2013109.e8.","DOI":"10.1016\/j.cmet.2020.10.002"},{"key":"ref271","doi-asserted-by":"publisher","unstructured":"Lu C, Yang D, Klement JD, Colson YL, Oberlies NH, Pearce CJ, et al. G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes. Journal for Immunotherapy of Cancer. 2022; 10: e003543.","DOI":"10.1136\/jitc-2021-003543"},{"key":"ref272","doi-asserted-by":"publisher","unstructured":"Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science (New York, N.Y.). 2016; 354: 481\u2013484.","DOI":"10.1126\/science.aaf6284"},{"key":"ref273","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Tom\u00e1s R, P\u00e9rez-Guill\u00e9n I. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers. 2020; 12: 3244.","DOI":"10.3390\/cancers12113244"},{"key":"ref274","doi-asserted-by":"publisher","unstructured":"Wan J, Shi JH, Shi M, Huang H, Zhang Z, Li W, et al. Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8+ T cells. Nature Cell Biology. 2025; 27: 972\u2013982.","DOI":"10.1038\/s41556-025-01673-2"},{"key":"ref275","doi-asserted-by":"publisher","unstructured":"Ji Y, Li X, Yao X, Sun J, Yi J, Shen Y, et al. Macrophage polarization: molecular mechanisms, disease implications, and targeted therapeutic strategies. Frontiers in Immunology. 2025; 16: 1732718.","DOI":"10.3389\/fimmu.2025.1732718"},{"key":"ref276","doi-asserted-by":"publisher","unstructured":"Li C, Liu C, Zhang J, Lu Y, Jiang B, Xiong H, et al. Pyruvate dehydrogenase kinase regulates macrophage polarization in metabolic and inflammatory diseases. Frontiers in Immunology. 2023; 14: 1296687.","DOI":"10.3389\/fimmu.2023.1296687"},{"key":"ref277","doi-asserted-by":"publisher","unstructured":"Au TY, Wi\u015bniewski OW, Benjamin S, Kubicki T, Dytfeld D, Gil L. G6PD deficiency-does it alter the course of COVID-19 infections? Annals of Hematology. 2023; 102: 1629\u20131636.","DOI":"10.1007\/s00277-023-05164-y"},{"key":"ref278","doi-asserted-by":"publisher","unstructured":"Shafqat A, Omer MH, Albalkhi I, Alabdul Razzak G, Abdulkader H, Abdul Rab S, et al. Neutrophil extracellular traps and long COVID. Frontiers in Immunology. 2023; 14: 1254310.","DOI":"10.3389\/fimmu.2023.1254310"},{"key":"ref279","doi-asserted-by":"publisher","unstructured":"Li J, Geng Y, Luo Y, Sun X, Guo Y, Dong Z. Pathological roles of NETs-platelet synergy in thrombotic diseases: From molecular mechanisms to therapeutic targeting. International Immunopharmacology. 2025; 159: 114934.","DOI":"10.1016\/j.intimp.2025.114934"},{"key":"ref280","doi-asserted-by":"publisher","unstructured":"Popovici-Muller J, Lemieux RM, Artin E, Saunders JO, Salituro FG, Travins J, et al. Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers. ACS Medicinal Chemistry Letters. 2018; 9: 300\u2013305.","DOI":"10.1021\/acsmedchemlett.7b00421"},{"key":"ref281","doi-asserted-by":"publisher","unstructured":"Zhu AX, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, et al. Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial. JAMA Oncology. 2021; 7: 1669\u20131677.","DOI":"10.1001\/jamaoncol.2021.3836"},{"key":"ref282","doi-asserted-by":"publisher","unstructured":"Cortes JE. Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia. Expert Review of Hematology. 2024; 17: 211\u2013221.","DOI":"10.1080\/17474086.2024.2354486"},{"key":"ref283","doi-asserted-by":"publisher","unstructured":"Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, et al. Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma. The New England Journal of Medicine. 2023; 389: 589\u2013601.","DOI":"10.1056\/NEJMoa2304194"},{"key":"ref284","doi-asserted-by":"publisher","unstructured":"de la Fuente MI, Touat M, van den Bent MJ, Preusser M, Peters KB, Young RJ, et al. The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. Neuro-oncology. 2025; 27: 1135\u20131148.","DOI":"10.1093\/neuonc\/noae259"},{"key":"ref285","doi-asserted-by":"publisher","unstructured":"Zhou J, Liang J, Gong Q, Zhang G, Li X, Zhang X, et al. A practical approach for the synthesis of lactate dehydrogenase A inhibitor GNE-140. Tetrahedron Letters. 2025; 154: 155395.","DOI":"10.1016\/j.tetlet.2024.155395"},{"key":"ref286","doi-asserted-by":"publisher","unstructured":"Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107: 2037\u20132042.","DOI":"10.1073\/pnas.0914433107"},{"key":"ref287","doi-asserted-by":"publisher","unstructured":"Kaushik N, Kaushik NK, Choi EH, Kim JH. Blockade of Cellular Energy Metabolism through 6-Aminonicotinamide Reduces Proliferation of Non-Small Lung Cancer Cells by Inducing Endoplasmic Reticulum Stress. Biology. 2021; 10: 1088.","DOI":"10.3390\/biology10111088"},{"key":"ref288","doi-asserted-by":"publisher","unstructured":"Mele L, Paino F, Papaccio F, Regad T, Boocock D, Stiuso P, et al. A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo. Cell Death & Disease. 2018; 9: 572.","DOI":"10.1038\/s41419-018-0635-5"},{"key":"ref289","doi-asserted-by":"publisher","unstructured":"Abdel-Wahab AF, Mahmoud W, Al-Harizy RM. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacological Research. 2019; 150: 104511.","DOI":"10.1016\/j.phrs.2019.104511"},{"key":"ref290","doi-asserted-by":"publisher","unstructured":"Ma R, Yun CH. Crystal structures of pan-IDH inhibitor AG-881 in complex with mutant human IDH1 and IDH2. Biochemical and Biophysical Research Communications. 2018; 503: 2912\u20132917.","DOI":"10.1016\/j.bbrc.2018.08.068"},{"key":"ref291","doi-asserted-by":"publisher","unstructured":"Koltai T, Fliegel L. Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts. Pharmaceuticals (Basel, Switzerland). 2024; 17: 744.","DOI":"10.3390\/ph17060744"},{"key":"ref292","doi-asserted-by":"publisher","unstructured":"Vlasiou M, Nicolaidou V, Papaneophytou C. Targeting Lactate Dehydrogenase-B as a Strategy to Fight Cancer: Identification of Potential Inhibitors by In Silico Analysis and In Vitro Screening. Pharmaceutics. 2023; 15: 2411.","DOI":"10.3390\/pharmaceutics15102411"},{"key":"ref293","doi-asserted-by":"publisher","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduction and Targeted Therapy. 2025; 10: 38.","DOI":"10.1038\/s41392-024-02082-x"},{"key":"ref294","doi-asserted-by":"publisher","unstructured":"Lin X, Xu Y, Bai E, Deng Y, Zhang W, Xue R, et al. 6-aminonicotinamide, a G6PD inhibitor, mitigates CAPS1 reduction mediated HCC metastasis via ERK and GSK3\u03b2 signals. Neoplasia (New York, N.Y.). 2025; 70: 101239.","DOI":"10.1016\/j.neo.2025.101239"},{"key":"ref295","doi-asserted-by":"publisher","unstructured":"Ding H, Chen Z, Wu K, Huang SM, Wu WL, LeBoeuf SE, et al. Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition. Science Advances. 2021; 7: eabk1023.","DOI":"10.1126\/sciadv.abk1023"},{"key":"ref296","doi-asserted-by":"publisher","unstructured":"Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends in Biochemical Sciences. 2014; 39: 347\u2013354.","DOI":"10.1016\/j.tibs.2014.06.005"},{"key":"ref297","doi-asserted-by":"publisher","unstructured":"Quinn J, Gerber B, Fouche R, Kenyon K, Blom Z, Muthukanagaraj P. Effect of High-Dose Vitamin C Infusion in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient. Case Reports in Medicine. 2017; 2017: 5202606.","DOI":"10.1155\/2017\/5202606"},{"key":"ref298","doi-asserted-by":"publisher","unstructured":"Lo YH, Mok KL. High dose vitamin C induced methemoglobinemia and hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency. The American Journal of Emergency Medicine. 2020; 38: 2488.e3\u20132488.e5.","DOI":"10.1016\/j.ajem.2020.05.099"},{"key":"ref299","doi-asserted-by":"publisher","unstructured":"Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I. Malate dehydrogenase-2 inhibitor LW6 promotes metabolic adaptations and reduces proliferation and apoptosis in activated human T-cells. Experimental and Therapeutic Medicine. 2015; 10: 1959\u20131966.","DOI":"10.3892\/etm.2015.2763"},{"key":"ref300","doi-asserted-by":"publisher","unstructured":"Kim HJ, Park MK, Byun HJ, Kim M, Kim B, Yu L, et al. LW1497, an Inhibitor of Malate Dehydrogenase, Suppresses TGF-\u03b21-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells by Downregulating Slug. Antioxidants (Basel, Switzerland). 2021; 10: 1674.","DOI":"10.3390\/antiox10111674"},{"key":"ref301","doi-asserted-by":"publisher","unstructured":"Naik R, Ban HS, Jang K, Kim I, Xu X, Harmalkar D, et al. Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1\/2 Inhibitor Targeting Cancer Metabolism. Journal of Medicinal Chemistry. 2017; 60: 8631\u20138646.","DOI":"10.1021\/acs.jmedchem.7b01231"},{"key":"ref302","doi-asserted-by":"publisher","unstructured":"Fermaintt CS, Wacker SA. Malate dehydrogenase as a multi-purpose target for drug discovery. Essays in Biochemistry. 2024; 68: 147\u2013160.","DOI":"10.1042\/EBC20230081"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/6\/10.31083\/FBL49369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:52:11Z","timestamp":1783421531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/6\/10.31083\/FBL49369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":302,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02035-6"],"URL":"https:\/\/doi.org\/10.31083\/fbl49369","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"article-number":"49369"}}